[3] Next-Generation Dual and Multi-Targeted Therapies on the Rise Amycretin: A Promising Dual GLP-1/Amylin Receptor Agonist Also making headlines at ADA 2025 was Amycretin (NNC0487-0111), a novel, unimolecular GLP-1 and amylin receptor agonist under development by Novo Nordisk
Weight loss on semaglutide without exercise is possible but sub-optimal from a body composition standpoint
Glutathione detoxifies the liver which results in turn results in brighter, clearer skin
Dosing Protocols and Administration Considerations BPC-157 dosing in published rodent studies typically ranges from 1020 micrograms per kilogram of body weight daily, administered subcutaneously
Chemokine (C-X-C motif) ligand 9 (Cxcl9) as a direct anti-regulatory molecule of VEGF signal generated by osteoblasts, regulating bone angiogenesis and osteogenesis
Rather than forcing yourself to eat more to hit an arbitrary calorie number, listen to your hunger cues and eat until satisfied